A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC
- Status
- RECRUITING
- Phase
- PHASE2
Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Chemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Combination Therapy for BRAF-V600E Metastatic CRCm
- Status
- RECRUITING
- Phase
- PHASE2
Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC
- Status
- RECRUITING
- Phase
- PHASE2
Safety of Effivia®, a Bevacizumab Biosimilar
- Status
- COMPLETED
- Phase
- N/A
Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
- Status
- TERMINATED
- Phase
- N/A
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Status
- RECRUITING
- Phase
- PHASE3
Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Sacituzumab Govitecan in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Second-line Treatment of Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
- Status
- RECRUITING
- Phase
- PHASE2